John P. McCabe - 01 Mar 2022 Form 4 Insider Report for Oncorus, Inc.

Reporting relationship: CFO and Treasurer
Issuer ticker: N/A
Reported as of: 01 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Mar 2022, 15:40:29 UTC
Source filing: View source filing
Reporting owner signature: /s/ Brian J. Shea, Attorney-in-Fact

Key filing fact

John P. McCabe filed Form 4 for Oncorus, Inc. on 02 Mar 2022.

Key facts

This page summarizes John P. McCabe's Form 4 filing for Oncorus, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2022, 15:40.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONCR transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +90,000
Change %
Price: $0.000000
Shares after: 90,000
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $2.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.